Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1053-1059

  Hirano, Ken Ichi ^a,c   Yamashita, Shizuya ^a   Nakajima, Norimichi ^b   Arai, Takeshi ^a   Maruyama, Takao ^a   Yoshida, Yu ^a   Ishigami, Masato ^a   Sakai, Naohiko ^a   Kameda Takemura, Kaoru ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Nakajima Clinic   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein deficiency; High density lipoprotein; Hyperalphalipoproteinemia; Longevity syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE MUTATION; HUMAN; HYPERLIPOPROTEINEMIA; JAPAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 16944362351     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1053     Document Type: Article

References (42)

1. Miller GJ, Miller NE. Plasma high-density-Iipoprotcin concentration and development of ischémie heart disease. Lancet. 1975;1: 16-19.
2. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. 1977;l:965-968.
3. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
4. Glueck CJ, Fallal RW, Millett F, Gartside P, Elston RC, Go RCP. Familial hyperalphalipoproteinemia: studies with eighteen kindreds. Metabolism. 1975;24:1243-1259.
5. Nikkila M, Heikkinen J. High density lipoprotein cholesterol and longevity. Age Ageing. 1990;19:119-124.
6. Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol. 1995;6:306-311.
7. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med. 1990;323:1234-1238.
8. Yamashita S, Matsuzawa Y, Okazaki M, Kako H, Yasugi T, Akioka H, Hirano K, Tarui S. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 1988;70:7-12.
9. Yamashita S, Sprecher DL, Sakai N, Matsuzawa Y, Tarui S, Hui DY. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990;86:688-695.
10. Sakai N, Matsuzawa Y, Hirano K, Yamashita S, Nozaki S, Ueyama Y, Kubo M, Tarui S. Detection of two species of low-density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler Thromb. 1991;11:71-79.
11. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989;342:448-451.
12. Arai T, Yamashita S, Sakai N, Hirano K, Ishigami M, Funahashi T, Nozaki S, Kameda-Takemura K, Matsuzawa Y. A novel nonsense mutation in the cholesteryl ester transfer protein gene causing marked hyperalphalipoproteinemia. J Lipid Res. 1996;37:2145-2154.
13. Takahashi K, Jiang XC, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki J, Kusunoki T, Miura P, Russie P, Tall AR. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest. 1993;92:2060-2064.
14. Hirano K, Yamashita S, Funahashi T, Sakai N, Menju M, Ishigami M, Hiraoka H, Kameda-Takemura K, Tokunaga K, Hoshino T, Kumasaka K, Kawano K, Matsuzawa Y. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population: relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 1993;100:85-90.
15. Matsuzawa Y, Yamashita S, Funahashi T, Yamanoto A, Tarui S. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper-HDL2-cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol. 1988;62: 66B-72B.
16. Matsuzawa Y, Yamashita S, Kameda K, Kubo M, Tarui S, Hara I. Marked hyper-HDL2-cholesteroIemia associated with premature corneal opacity: a case report. Atherosclerosis. 1984;53:207-212.
17. Carlson LA, Philipson B. Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia. Lancet. 1979;2:921-923.
18. Sakai N, Yamashita S, Hirano K, Arai T, Yoshida Y, Menju M, Ishigami M, Hoshino T, Nakajima N, Kameda-Takemura K, Matsuzawa Y. Frequency of exon 15 missense mutation (D442: O) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 1995;114:139-146.
19. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki N, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, KamedaTakemura K, Hayashi K, Matsuzawa Y. Atherosclerotic disease in marked hyperalphalipoproteinemia: combined reduction of cholesteryl ester transfer protein and hepatic triglycéride lipase. Arlerioscler Thromb Vase Biol. 1995;15:1849-1856.
20. Cholesterol in high density lipoprotein: use of Mg2Vdextran sulfate in its enzymic measurement. Clin Chem. 1978;24:24-30.
21. Kato H, Nakanishi T, Arai H, Nishida H, Nishida T. Purification, microheterogeneity, and stability of human lipid transfer protein. J Biol Chem. 1989:264:4082-4087.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
23. Hishinuma J. Municipal Life Tables 1990. Health and Welfare Statistics Association; 1993:44-45.
24. Goto Y, Akanuma Y, Harano Y, Hata Y, Itakura H, Kajinami G, Kawade M, Koga S, Kuzuya F, Maruhama Y, Matsuzawa Y, Murai A, Murase T, Naito C, Nakai T, Noma A, Saito Y, Sasaki J, Takeuchi N, Tamachi H, Uzawa H, Yamamoto A, Yamazaki S, Yasugi T, Yukawa S. Determination by the SRID method of normal values of serum apolipoproteins (A-I, A-II, B, C-II, C-III, and E) in normolipidemic healthy subjects. J Clin Biochem Nutr. 1986;1:73-88.
25. Matsunaga A, Araki K, Moriyama K, Handa K, Arakawa F, Nishi K, Sasaki J, Arakawa K. Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesis. Biochim Biophys Ada. 1993;1166:131-I34.
26. Inazu A, Koizumi J, Haraki T, Yagi K, Wakasugi T, Takegoshi T, Mabuchi H, Takeda R. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. Hum Genet. 1993;91:13-16.
27. Gordon T, Ernst N, Fisher M, Rifkind BM. Alcohol and high-density lipoprotein cholesterol. Circulation. 1981;64(suppl III):III-63-III-67.
28. Kagan A, Yano K, Rhoads GC, McGee DL. Alcohol and cardiovascular disease: the Hawaiian experience. Circulation. 1981;64(suppl III):III-27-III-31.
29. Gordon T, Castelli WP, Hjortland ML. High density lipoproteins as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
30. Alvarez C, Orejas A, Gonzalez S, Diaz R, Colomo LF. Reference intervals for serum lipids, lipoproteins, and apolipoproteins in the elderly. Clin Chem. 1984;30:404-406.
31. Sutherland SE, Gazes PC, Keil JE, Gilbert GE, Knapp G. Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart Study. Circulation. 1993;88:2685-2692.
32. Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport: insight from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 1989;9:785-795.
33. Sakai N, Yamashita S, Hirano K, Ueyama Y, Funahashi T, Kubo M, Matsuzawa Y. Decreased affinity of low density lipoprotein panicles to LDL receptors in patients with cholesteryl ester transfer protein deficiency. Ear J Clin Invest. 1995;25:332-339.
34. Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, KamedaTakemura K, Matsuzawa Y. Large and cholesteryl ester-rich high density lipoproteins in cholesteryl ester transfer protein deficiency cannot prevent macrophages from cholesterol accumulation induced by acetylated low density lipoproteins. J Biochem (Tokyo). 1994;116:257-262.
35. Yamashita S, Ishigami M, Arai T, Sakai N, Hirano K, Matsuzawa Y. Very high density lipoproteins (VHDL) induced by plasma cholesteryl ester transfer protein (CETP) have a potent anti-atherogenic function. Ann N YAcadSci. 1995;748:606-608.
36. Franceschini G, Chiesa G, Sirtori CR. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. Eur J Clin Invest. 1991;21:384-388.
37. Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, Yamashita S, Kubo M, Tarui S. Polydisperse low density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism. 1992;41:1313-1318.
38. Hirano K, Yamashita S, Sakai N, Hiraoka H, Ueyama Y, Funahashi T, Matsuzawa Y. Low density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low density lipoprotein receptor, din Biochem. 1992;25:357-362.
39. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest. 1995;96:2071-2074.
40. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. Deletion in the gene for the low density lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N EnglJMed. 1987:317:734-737.
41. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill; 1989:1251-1266.
42. Weitzman JB, Vladutiu AO. Very high values of serum high density lipoprotein cholesterol. Arch Pathol Lab Med. 1992;116:831-836.